Watchlist Manager

Watchlist

Price: 8 620 KRW 2.5% Market Closed

Market Cap: ₩137.7B

	Jeil Pharma Holdings Inc KRX:002620	KR

Balance Sheet

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	3 152	6 358	5 490	7 126	7 245	7 754	9 849	16 626	28 627	25 641	22 661	11 713	7 670	8 066	13 489	30 021	8 754	41 098	21 237	20 183	28 581	34 760	37 039	59 821
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	174	251	66	7	77	7 493	122	3 012	674	586	4 348
Cash Equivalents	3 152	6 358	5 490	7 126	7 245	7 754	9 849	16 626	28 627	25 641	22 661	11 713	7 670	7 892	13 238	29 955	8 747	41 021	13 744	20 061	25 568	34 085	36 452	55 473
Short-Term Investments	1 093	1 480	1 903	1 551	1 249	1 457	1 524	2 509	17 146	25 823	29 445	9 988	11 361	4 096	3 098	3 151	4 843	3 335	3 875	9 778	18 643	18 643	22 092	16 062
Total Receivables	56 518	59 024	64 246	81 928	80 564	95 575	93 911	87 448	105 038	130 510	137 644	135 696	154 971	182 338	198 161	196 717	18 632	195 020	186 042	180 349	165 490	178 157	194 297	202 528
Accounts Receivables	55 178	56 983	62 001	78 397	79 310	90 889	89 111	82 763	102 498	127 446	133 855	131 978	151 540	178 308	193 402	188 971	16 384	178 888	169 168	166 799	149 755	162 610	178 870	188 389
Other Receivables	1 340	2 041	2 245	3 531	1 254	4 686	4 800	4 685	2 540	3 064	3 789	3 718	3 431	4 030	4 759	7 746	2 248	16 132	16 874	13 550	15 736	15 547	15 427	14 140
Inventory	19 315	21 471	25 343	27 018	41 220	51 275	62 496	75 603	46 075	56 096	65 600	66 945	63 615	58 773	73 623	80 452	6 255	97 563	96 784	124 150	114 243	113 266	125 280	123 669
Other Current Assets	934	840	1 005	344	1 359	1 364	1 041	1 151	665	2 068	2 375	1 659	1 038	524	823	2 409	39	912	5 682	613	8 187	8 091	5 819	7 480
Total Current Assets	81 012	89 173	97 987	117 967	131 636	157 425	168 822	183 338	197 550	240 138	257 724	226 000	238 655	253 797	289 194	312 750	38 523	337 928	313 620	335 074	335 144	352 916	384 527	409 561
PP&E Net	33 133	36 615	47 214	46 439	52 313	53 065	54 194	46 361	47 358	45 721	65 994	104 965	98 476	93 289	92 083	115 160	5 061	135 598	163 309	170 479	212 965	233 120	228 862	243 942
PP&E Gross	33 133	36 615	47 214	46 439	52 313	53 065	54 194	46 361	47 358	45 721	65 994	104 965	98 476	93 289	92 083	115 160	5 061	135 598	163 309	170 479	212 965	233 120	228 862	243 942
Accumulated Depreciation	16 720	20 755	26 042	31 282	36 523	41 624	45 959	49 482	53 468	52 821	56 531	62 627	70 035	78 060	84 281	91 380	8 665	111 016	119 826	127 872	134 439	142 229	152 460	162 233
Intangible Assets	1 149	740	444	236	151	154	207	236	376	3 946	3 959	3 841	4 003	5 272	4 813	4 373	16	4 373	4 350	4 118	3 781	9 472	13 093	13 762
Goodwill	0	608	486	355	0	0	0	0	0	0	0	0	0	0	0	0	0	266 348	168 815	168 815	151 801	73 466	44 862	0
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2 712	2 287	0	0	0	0	0	0	0	0
Long-Term Investments	5 598	4 916	4 680	8 093	14 521	19 565	26 379	32 918	39 875	55 983	56 455	55 959	54 963	57 198	56 353	57 405	200 070	172 706	189 987	203 084	185 887	191 958	198 606	211 200
Other Long-Term Assets	3 929	4 077	2 617	2 963	4 263	4 278	4 854	4 460	4 888	0	0	0	0	12	11	11	438	3 132	5 204	5 825	2 843	4 744	10 046	11 969
Other Assets	0	608	486	355	0	0	0	0	0	0	0	0	0	0	0	0	0	266 348	168 815	168 815	151 801	73 466	44 862	0
Total Assets	124 822 N/A	136 129 +9%	153 429 +13%	176 054 +15%	202 884 +15%	234 486 +16%	254 456 +9%	267 312 +5%	290 048 +9%	345 789 +19%	384 131 +11%	390 765 +2%	396 097 +1%	409 567 +3%	445 166 +9%	491 985 +11%	244 108 -50%	920 086 +277%	845 285 -8%	887 395 +5%	892 421 +1%	865 677 -3%	879 997 +2%	890 433 +1%
Liabilities
Accounts Payable	11 050	17 906	25 128	33 690	43 874	62 388	69 844	66 382	59 554	87 013	101 500	89 669	108 143	107 426	129 398	140 161	5 000	151 127	157 545	149 265	159 388	162 967	154 050	146 189
Accrued Liabilities	22	28	24	8	26	20	200	39	12	433	435	50	52	50	8	78	0	35	178	170	145	219	289	379
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	7 627	0	25 500	679	89 578	101 604	130 510	88 033	115 195	141 030	141 872
Current Portion of Long-Term Debt	20 759	15 560	15 219	9 469	15 452	12 000	6 085	11 000	6 000	6 000	6 000	16 376	6 000	1 000	21 345	3 958	0	5 594	6 889	6 699	6 932	3 892	6 508	673
Other Current Liabilities	12 664	10 307	14 337	14 043	11 565	17 094	22 638	19 455	25 448	24 600	22 643	15 147	15 773	27 016	24 278	23 858	9 689	34 643	47 613	40 674	43 526	76 231	110 759	88 878
Total Current Liabilities	44 495	43 801	54 708	57 210	70 917	91 502	98 767	96 877	91 015	118 047	130 578	121 243	129 968	143 119	175 030	193 554	15 368	280 977	313 829	327 317	298 024	358 505	412 636	377 991
Long-Term Debt	4 688	3 014	1 921	4 453	1 086	145	60	0	0	0	0	8 000	8 000	7 000	5 000	27 500	0	19 906	14 102	12 585	20 108	17 477	11 698	12 667
Deferred Income Tax	2 448	2 850	2 578	2 256	5 126	6 451	7 283	5 679	6 730	9 847	12 178	11 379	11 094	9 178	7 285	6 305	15 802	19 695	23 016	31 826	37 747	35 755	37 618	40 892
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3 139	3 703	99 243	88 640	91 832	88 583	82 028	82 725	130 447
Other Liabilities	3 338	2 580	4 444	6 191	8 774	9 330	8 579	9 427	8 640	9 023	9 979	8 737	9 432	15 058	16 462	12 546	6 214	9 932	12 491	16 383	36 229	34 148	15 859	21 486
Total Liabilities	54 969 N/A	52 245 -5%	63 651 +22%	70 110 +10%	85 903 +23%	107 427 +25%	114 689 +7%	111 983 -2%	106 385 -5%	136 917 +29%	152 736 +12%	149 360 -2%	158 495 +6%	174 354 +10%	203 778 +17%	243 044 +19%	41 086 -83%	429 752 +946%	452 077 +5%	479 943 +6%	480 691 +0%	527 912 +10%	560 536 +6%	583 483 +4%
Equity
Common Stock	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	7 425	2 173	7 987	7 987	7 987	7 987	7 987	7 987	7 987
Retained Earnings	41 100	55 143	62 973	79 067	89 970	99 299	111 670	127 838	155 053	180 777	204 846	215 703	214 666	212 703	219 963	226 725	766 743	261 231	164 620	175 785	172 151	98 245	79 119	26 146
Additional Paid In Capital	2 203	2 203	2 203	2 203	2 751	2 753	2 784	2 732	2 777	2 203	2 203	2 203	2 203	2 203	2 203	4 063	680 075	86 932	82 431	87 606	90 000	89 674	90 138	115 441
Unrealized Security Profit/Loss	20 191	20 179	20 223	20 296	20 429	20 441	20 823	20 200	21 332	20 719	19 634	20 186	20 438	19 785	20 414	20 104	30 982	51 222	55 208	53 112	58 631	58 898	59 256	74 414
Treasury Stock	1 146	1 101	3 156	3 230	3 594	2 860	2 936	2 867	2 925	2 797	3 258	4 657	7 674	7 702	10 827	10 827	3 422	3 422	3 422	3 422	3 422	3 422	3 422	3 422
Other Equity	80	35	110	183	0	0	0	0	0	545	545	545	545	800	2 210	1 450	86 621	86 384	86 384	86 384	86 384	86 384	86 384	86 384
Total Equity	69 852 N/A	83 884 +20%	89 777 +7%	105 944 +18%	116 981 +10%	127 059 +9%	139 766 +10%	155 329 +11%	183 663 +18%	208 872 +14%	231 395 +11%	241 405 +4%	237 602 -2%	235 213 -1%	241 388 +3%	248 941 +3%	203 022 -18%	490 334 +142%	393 208 -20%	407 452 +4%	411 731 +1%	337 765 -18%	319 461 -5%	306 950 -4%
Total Liabilities & Equity	124 822 N/A	136 129 +9%	153 429 +13%	176 054 +15%	202 884 +15%	234 486 +16%	254 456 +9%	267 312 +5%	290 048 +9%	345 789 +19%	384 131 +11%	390 765 +2%	396 097 +1%	409 567 +3%	445 166 +9%	491 985 +11%	244 108 -50%	920 086 +277%	845 285 -8%	887 395 +5%	892 421 +1%	865 677 -3%	879 997 +2%	890 433 +1%
Shares Outstanding
Common Shares Outstanding	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	15	15	15	15	15	15	15

Income Statement Balance Sheet Cash Flow Statement

Jeil Pharma Holdings Inc
KRX:002620

Balance Sheet

Balance Sheet Decomposition
Jeil Pharma Holdings Inc

Balance Sheet
Jeil Pharma Holdings Inc

See Also

Company

Help

Tools

Stocks

Jeil Pharma Holdings Inc KRX:002620

Balance Sheet

Balance Sheet Decomposition Jeil Pharma Holdings Inc

Balance Sheet Jeil Pharma Holdings Inc

See Also

Company

Help

Tools

Stocks

Jeil Pharma Holdings Inc
KRX:002620

Balance Sheet Decomposition
Jeil Pharma Holdings Inc

Balance Sheet
Jeil Pharma Holdings Inc